402 related articles for article (PubMed ID: 28342216)
21. Case of pemphigus herpetiformis with immunoglobulin G autoantibodies against desmocollin-3.
Ansai O; Shimomura Y; Fujimoto A; Sakai A; Tsuchida Y; Hayashi R; Shigehara Y; Hama N; Abe R
J Dermatol; 2017 Jan; 44(1):104-105. PubMed ID: 27177601
[No Abstract] [Full Text] [Related]
22. Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin.
Sitaru C; Schmidt E; Petermann S; Munteanu LS; Bröcker EB; Zillikens D
J Invest Dermatol; 2002 Apr; 118(4):664-71. PubMed ID: 11918714
[TBL] [Abstract][Full Text] [Related]
23. Antidesmoglein autoantibodies in silicosis patients with no bullous diseases.
Ueki H; Kohda M; Nobutoh T; Yamaguchi M; Omori K; Miyashita Y; Hashimoto T; Komai A; Tomokuni A; Ueki A
Dermatology; 2001; 202(1):16-21. PubMed ID: 11244222
[TBL] [Abstract][Full Text] [Related]
24. Antibodies to desmogleins 1 and 3, but not to BP180, induce blisters in human skin grafted onto SCID mice.
Zillikens D; Schmidt E; Reimer S; Chimanovitch I; Hardt-Weinelt K; Rose C; Bröcker EB; Kock M; Boehncke WH
J Pathol; 2001 Jan; 193(1):117-24. PubMed ID: 11169524
[TBL] [Abstract][Full Text] [Related]
25. Management of erythematous skin lesions in bullous pemphigoid associated with atopic dermatitis.
Kamiya K; Aoyama Y; Nishio E; Horio A; Tokura Y
J Dermatol; 2016 Sep; 43(9):1102-3. PubMed ID: 26946485
[No Abstract] [Full Text] [Related]
26. [Evaluation of histological criteria for bullous pemphigoid. Correlation with antigens recognized by immunoblotting of anti-epidermal autoantibodies].
Courville P; Kupfer I; Gilbert D; Thomine E; Metayer J; Joly P
Ann Pathol; 2000 Dec; 20(6):564-9. PubMed ID: 11148352
[TBL] [Abstract][Full Text] [Related]
27. Combination therapy of prednisolone and i.v. immunoglobulin treatment decreases circulating interleukin-5 and eosinophils in a patient with bullous pemphigoid.
Yamashita C; Nakamizo S; Honda Y; Dainichi T; Kabashima K
J Dermatol; 2017 Jan; 44(1):101-102. PubMed ID: 27154738
[No Abstract] [Full Text] [Related]
28. Immunoglobulin A antibodies against desmoglein 1, envoplakin, periplakin and BP230 in a patient with atypical bullous pemphigoid.
Yamaki F; Mayuzumi N; Ikeda S; Hashimoto T
J Dermatol; 2010 Mar; 37(3):255-8. PubMed ID: 20507390
[TBL] [Abstract][Full Text] [Related]
29. [Anti-p200 pemphigoid: Remission under mycophenolate mofetil (Cellcept®)].
Raffin D; Delaplace M; Roussel A; Estève E
Ann Dermatol Venereol; 2013 Dec; 140(12):784-7. PubMed ID: 24315224
[TBL] [Abstract][Full Text] [Related]
30. A case of pemphigoid vegetans with autoantibodies against both BP180 and BP230 antigens.
Suda-Takayanagi T; Hara H; Ohyama B; Hashimoto T; Terui T
J Am Acad Dermatol; 2011 Jan; 64(1):206-8. PubMed ID: 21167421
[No Abstract] [Full Text] [Related]
31. Coexistence of pemphigus vulgaris and bullous pemphigoid in the upper aerodigestive tract.
Tabuchi K; Nomura M; Murashita H; Fujisawa Y; Tsuji S; Okubo H; Hara A
Auris Nasus Larynx; 2006 Jun; 33(2):231-3. PubMed ID: 16168587
[TBL] [Abstract][Full Text] [Related]
32. Non-paraneoplastic autoimmune subepidermal bullous disease associated with fatal bronchiolitis obliterans.
Orime M; Tomiyama K; Hashidate H; Yoshida S; Hokari S; Tsuda A; Yokoyama H; Narita JI; Uchida Y; Kanekura T; Abe R; Ishii N; Hashimoto T; Kawai K
J Dermatol; 2017 Apr; 44(4):461-464. PubMed ID: 27914107
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous occurrence of anti-BP180 mucous membrane pemphigoid and mucosal-dominant pemphigus vulgaris.
Kobayashi K; Tanaka M; Nakajima S; Ito H; Harada T; Hashimoto T
Clin Exp Dermatol; 2009 Dec; 34(8):e785-8. PubMed ID: 19778312
[TBL] [Abstract][Full Text] [Related]
34. Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid.
Ishiura N; Fujimoto M; Watanabe R; Nakashima H; Kuwano Y; Yazawa N; Echigo T; Okochi H; Tamaki K
J Dermatol Sci; 2008 Feb; 49(2):153-61. PubMed ID: 17920818
[TBL] [Abstract][Full Text] [Related]
35. Tetracycline and niacinamide control bullous pemphigoid but not pemphigus foliaceus when these conditions coexist.
Shiohara J; Yoshida K; Hasegawa J; Uhara H; Takata M; Saida T; Ohyama B; Hashimoto T
J Dermatol; 2010 Jul; 37(7):657-61. PubMed ID: 20629832
[TBL] [Abstract][Full Text] [Related]
36. Infliximab-induced bullous pemphigoid and anti-desmoglein 3 and anti-BP180 autoantibodies in a patient with ulcerative colitis.
Tani N; Sugita K; Yanagihara S; Yamamoto O
Eur J Dermatol; 2019 Feb; 29(1):88-90. PubMed ID: 30530408
[No Abstract] [Full Text] [Related]
37. IgE-mediated mechanisms in bullous pemphigoid and other autoimmune bullous diseases.
van Beek N; Schulze FS; Zillikens D; Schmidt E
Expert Rev Clin Immunol; 2016; 12(3):267-77. PubMed ID: 26588556
[TBL] [Abstract][Full Text] [Related]
38. Development of an ELISA to detect anti-BP180 autoantibodies in bullous pemphigoid and herpes gestationis.
Giudice GJ; Wilske KC; Anhalt GJ; Fairley JA; Taylor AF; Emery DJ; Hoffman RG; Diaz LA
J Invest Dermatol; 1994 Jun; 102(6):878-81. PubMed ID: 7516396
[TBL] [Abstract][Full Text] [Related]
39. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles.
Tanaka M; Hashimoto T; Dykes PJ; Nishikawa T
Clin Exp Dermatol; 1996 Jan; 21(1):23-7. PubMed ID: 8689764
[TBL] [Abstract][Full Text] [Related]
40. Bullous pemphigoid associated with milia, increased serum IgE, autoantibodies against desmogleins, and refractory treatment in a young patient.
Ding S; Deng Q; Xiang Y; Chen J; Huang J; Lu J
An Bras Dermatol; 2017; 92(5 Suppl 1):34-36. PubMed ID: 29267440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
